Dr. Chakroborty is a Program Director in the Translational Research Branch, Division of Neuroscience, at the National Institute on Aging (NIA). She manages a portfolio of drug discovery and drug development for biologics and the Alzheimer’s Disease Preclinical Efficacy Database (AlzPED).
Dr. Chakroborty earned her Ph.D. in Neuroscience from the Chicago Medical School/Rosalind Franklin University of Medicine and Science in Chicago where she conducted research on the impact of altered calcium signaling on hippocampal synaptic transmission and plasticity in Alzheimer’s disease. After her Ph.D., Dr. Chakroborty completed a postdoctoral fellowship at Rosalind Franklin University of Medicine and Science examining the molecular and cellular processes underlying neuronal and network function and dysfunction associated with neurological and movement disorders.